Survey of Canadian human blood plasma for ochratoxin A.

Blood plasma samples collected from 144 healthy volunteers in 16 locations across Canada in 1994 were analysed for ochratoxin A (OTA). The method of analysis included cleanup by C18 solid phase extraction and immunoaffinity columns followed by liquid chromatography (LC) with fluorescence detection, which gave 86.5% (s.d. = 9.7) recovery (n = 31) of OTA (added at 2 ng/ml) with a detection limit of 0.15 ng/ml. The arithmetic mean concentration found in the plasma samples, corrected for volume of anticoagulant added, was 0.88 ng/ml with a standard deviation of 0.35 ng/ml and a range of 0.29-2.37 ng/ml. Confirmation of identity of OTA was by methyl ester formation for 65 samples and by LC-tandem mass spectrometry for 17 samples (some of which were included in pooled samples). Statistical analysis, by ANOVA of the log OTA plasma concentrations, showed a highly significant effect due to location in Canada (p = < 0.0001) but no effect due to age, sex or blood group of donors. The highest mean concentration was found in Winnipeg, significantly different (p = 0.05) by the Student-Newman-Keuls multiple range test from the lowest levels found in Toronto, Vancouver and Saint John.

[1]  M. Castegnaro,et al.  Occurrence and significance of ochratoxin A in food. , 1998, Food additives and contaminants.

[2]  A. Lucic,et al.  Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. , 1996, Toxicology letters.

[3]  A. Wölfling,et al.  Ochratoxin A content of human sera determined by a sensitive ELISA. , 1997, Journal of analytical toxicology.

[4]  J. Varga,et al.  Ochratoxin production by Aspergillus species , 1996, Applied and environmental microbiology.

[5]  Brera,et al.  Application of Biomarkers to Assessment of Risk to Human Health from Exposure to Mycotoxins , 1996, Microchemical journal : devoted to the application of microtechniques in all branches of science.

[6]  H. Bacha,et al.  Human Nephropathy Related to Ochratoxin a in Tunisia , 1996 .

[7]  T. Troxell,et al.  Identification and reduction of sources of dietary lead in the United States. , 1996, Food additives and contaminants.

[8]  C. Schlatter,et al.  Carcinogenicity and kinetic aspects of ochratoxin A. , 1996, Food additives and contaminants.

[9]  M. Hammami,et al.  Ochratoxin A in human blood in relation to nephropathy in Tunisia , 1995, Human & experimental toxicology.

[10]  B Zimmerli,et al.  Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. , 1995, Journal of chromatography. B, Biomedical applications.

[11]  F. Jonsyn,et al.  Human fetal exposure to ochratoxin A and aflatoxins. , 1995, Annals of tropical paediatrics.

[12]  F. Kovács,et al.  Detection of ochratoxin a in human blood and colostrum. , 1995, Acta veterinaria Hungarica.

[13]  K. Hult,et al.  Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. , 1994, Natural toxins.

[14]  K. Hult,et al.  Ochratoxin A in cow's milk and in human milk with corresponding human blood samples. , 1993, Journal of AOAC International.

[15]  V. Ostry,et al.  Study of human exposure to ochratoxin A and assessment of possible sources. , 1993, Central European journal of public health.

[16]  R. R. Marquardt,et al.  A review of recent advances in understanding ochratoxicosis. , 1992, Journal of animal science.

[17]  K. Hult,et al.  Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. , 1991, Food additives and contaminants.

[18]  M Castegnaro,et al.  Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary tract tumours in Bulgaria. , 1988, IARC scientific publications.

[19]  K. Ominski,et al.  Ochratoxin A as a contaminant in the human food chain: a Canadian perspective. , 1991, IARC scientific publications.

[20]  H. Bartsch,et al.  Human ochratoxicosis in France. , 1991, IARC scientific publications.

[21]  B. Hald Ochratoxin A in human blood in European countries. , 1991, IARC scientific publications.

[22]  K. Hult,et al.  Possible sources of ochratoxin A in human blood in Poland. , 1991, IARC scientific publications.

[23]  T. Kuiper-Goodman Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenone. , 1990, Canadian journal of physiology and pharmacology.

[24]  L. Fukal,et al.  Monitoring of aflatoxins and ochratoxin A in Czechoslovak human sera by immunoassay , 1990, Bulletin of environmental contamination and toxicology.

[25]  P. Scott,et al.  Risk assessment of the mycotoxin ochratoxin A. , 1989, Biomedical and environmental sciences : BES.

[26]  K. Hult,et al.  Toxicokinetics of ochratoxin A in several species and its plasma‐binding properties , 1989, Journal of applied toxicology : JAT.

[27]  K. Hult,et al.  High affinity binding of ochratoxin A to plasma constituents. , 1984, Biochemistry international.